Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NICE (UK National Institute for Clinical Excellence) considers ultrasound-guided CVA (central venous access)

This article was originally published in Clinica

Executive Summary

The National Institute for Clinical Excellence (NICE) held this week the second appraisal committee meeting on the use of ultrasonic location devices during the insertion of central venous lines. Preliminary guidance recommends that two-dimensional imaging ultrasound be used in the more than 200,000 central venous access (CVA) procedures performed annually by the NHS in England and Wales. In its assessment of CVA technologies, NICE also compares audio-guided Doppler ultrasound location with the traditional, so-called "landmark" method.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT066383

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel